| An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile LC McDonald, GE Killgore, A Thompson, RC Owens Jr, SV Kazakova, ... New England Journal of Medicine 353 (23), 2433-2441, 2005 | 2633 | 2005 |
| Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial … TH Dellit, RC Owens, JE McGowan, DN Gerding, RA Weinstein, JP Burke, ... Clinical infectious diseases 44 (2), 159-177, 2007 | 2424 | 2007 |
| Antimicrobial-Associated Risk Factors for Clostridium difficile Infection RC Owens Jr, CJ Donskey, RP Gaynes, VG Loo, CA Muto Clinical Infectious Diseases 46 (Supplement_1), S19-S31, 2008 | 821 | 2008 |
| Antimicrobial safety: focus on fluoroquinolones RC Owens Jr, PG Ambrose Clinical infectious diseases 41 (Supplement_2), S144-S157, 2005 | 627 | 2005 |
| Measures to Control and Prevent Clostridium difficile Infection DN Gerding, CA Muto, RC Owens Jr Clinical Infectious Diseases 46 (Supplement_1), S43-S49, 2008 | 466 | 2008 |
| Treatment of Clostridium difficile Infection DN Gerding, CA Muto, RC Owens Jr Clinical Infectious Diseases 46 (Supplement_1), S32-S42, 2008 | 405 | 2008 |
| Antimicrobial-associated QT interval prolongation: pointes of interest EJC Goldstein, RC Owens Jr, TD Nolin Clinical Infectious Diseases 43 (12), 1603-1611, 2006 | 300 | 2006 |
| Antimicrobial stewardship: concepts and strategies in the 21st century RC Owens Jr Diagnostic microbiology and infectious disease 61 (1), 110-128, 2008 | 286 | 2008 |
| Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains WN Fawley, S Underwood, J Freeman, SD Baines, K Saxton, ... Infection Control & Hospital Epidemiology 28 (8), 920-925, 2007 | 237 | 2007 |
| Clinical use of the fluoroquinolones RC Owens Jr, PG Ambrose Medical Clinics of North America 84 (6), 1447-1469, 2000 | 220 | 2000 |
| QT prolongation with antimicrobial agents: understanding the significance RC Owens Drugs 64, 1091-1124, 2004 | 176 | 2004 |
| Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies P Ball, R Stahlmann, R Kubin, S Choudhri, R Owens Clinical therapeutics 26 (7), 940-950, 2004 | 172 | 2004 |
| Need and potential of antimicrobial stewardship in community hospitals EJ Septimus, RC Owens Jr Clinical infectious diseases 53 (suppl_1), S8-S14, 2011 | 167 | 2011 |
| Torsades de pointes associated with fluoroquinolones. RC Owens Jr, PG Ambrose Pharmacotherapy 22 (5), 663-8; discussion 668, 2002 | 133 | 2002 |
| Hospital-based strategies for combating resistance RC Owens Jr, L Rice Clinical infectious diseases 42 (Supplement_4), S173-S181, 2006 | 121 | 2006 |
| Antimicrobial stewardship programs as a means to optimize antimicrobial use insights from the Society of Infectious Diseases Pharmacists RC Owens Jr, GL Fraser, P Stogsdill Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 24 (7 …, 2004 | 113 | 2004 |
| Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional … SD Pope, TH Dellit, RC Owens, TM Hooton Infection Control & Hospital Epidemiology 30 (1), 97-98, 2009 | 108 | 2009 |
| Clinical pharmacodynamics of quinolones PG Ambrose, SM Bhavnani, RC Owens Infectious Disease Clinics 17 (3), 529-543, 2003 | 102 | 2003 |
| Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for … RH Drew, R White, C MacDougall, ED Hermsen, RC Owens Jr Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (5 …, 2009 | 101 | 2009 |
| Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies RC Owens Jr, AF Shorr American Journal of Health-System Pharmacy 66 (12_Supplement_4), S23-S30, 2009 | 87 | 2009 |